| Literature DB >> 25927297 |
Yinyin Zang1,2, Nigel Hunt3, Tom Cox4,5.
Abstract
BACKGROUND: Narrative exposure therapy (NET) is a brief, manualised treatment for Posttraumatic Stress Disorder (PTSD). It has been shown to have therapeutic benefits for a wide range of individuals and settings. This study, following our previous work applying the original NET in earthquake survivors, aimed to revise NET to be adaptable for treating PTSD after a natural disaster.Entities:
Mesh:
Year: 2014 PMID: 25927297 PMCID: PMC4189751 DOI: 10.1186/s12888-014-0262-3
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Comparison of the treatment processes of the original NET and revised NET
|
|
| |
|---|---|---|
|
| ● Introduction | ● Introduction |
| ● Pre-treatment diagnostics | ● Pre-treatment diagnostics | |
| ● Psychoeducation | ● Psychoeducation | |
|
| ● Lifeline | ● Starting the earthquake narration |
| ● Starting the narration beginning birth continuing through to the first traumatic event | ||
|
| ● Reading of the narrative collected in previous sessions. Continuing the narration of subsequent life and traumatic events | ● Continuing the narration of the earthquake if needed |
|
| ● Rereading and signing whole document | ● Lifeline |
| ● Narrating from birth to current time, including reading of the earthquake narrative collected in previous sessions. | ||
| ● Reading the recorded final autobiography | ||
|
| ➢ Weekly or biweekly | ➢ 1-2 days interval |
Figure 1CONSORT diagram showing the flow of participants through each group.
Sociodemographic characteristics of participants within the three treatment groups
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
| ||||
|
| 2.22 | 0.33 | |||
| Male | 1 | 2 | 0 | ||
| Female | 9 | 8 | 10 | ||
|
| 2.65 | 0.62 | |||
| Single | 0 | 1 | 0 | ||
| Married | 8 | 6 | 8 | ||
| Divorced or widowed | 2 | 3 | 2 | ||
|
| 1.25 | 0.54 | |||
| Primary school or below | 7 | 9 | 8 | ||
| Junior middle school | 3 | 1 | 2 | ||
|
| 2.24 | 0.70 | |||
| No fixed income | 4 | 6 | 7 | ||
| Below £100 | 2 | 2 | 1 | ||
| £100-£300 | 4 | 2 | 2 | ||
|
| 3.36 | 0.17 | |||
| Partially damaged | 0 | 3 | 2 | ||
| Slightly damaged | 10 | 7 | 8 | ||
|
| 1.36 | 0.51 | |||
| Yes | 4 | 2 | 2 | ||
| No | 6 | 8 | 8 | ||
|
| 5.16 | 0.08 | |||
| Yes | 8 | 3 | 6 | ||
| No | 2 | 7 | 4 | ||
|
| 6.00 | 0.20 | |||
| No | 8 | 8 | 8 | ||
| Once | 0 | 0 | 2 | ||
| 2 or 3 times | 2 | 2 | 0 | ||
|
| M(SD) | M(SD) | M(SD) |
|
|
| 53.50 (1.24) | 56.50 (1.47) | 50.90 (1.23) | 0.45 | 0.64 | |
Measures over time for NET, NET-R and WL groups
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||
|
|
| 50.90 | 10.65 | 17.00 | 6.72 | 16.10 | 6.85 | 12.70 | 9.59 |
|
| 52.10 | 9.06 | 16.90 | 4.93 | 16.50 | 4.81 | 12.70 | 6.48 | |
|
| 56.80 | 10.91 | 54.70 | 10.81 | 16.60 | 5.13 | 13.80 | 6.63 | |
|
|
| 9.90 | 8.80 | 2.70 | 3.23 | 2.40 | 3.03 | 1.60 | 2.59 |
|
| 15.80 | 7.33 | 1.30 | 2.06 | 1.70 | 2.31 | 0.60 | 1.26 | |
|
| 14.40 | 5.62 | 14.30 | 6.15 | 0.80 | 1.48 | 0.50 | 0.97 | |
|
|
| 10.50 | 3.69 | 4.60 | 4.14 | 5.00 | 3.20 | 3.90 | 4.93 |
|
| 10.60 | 3.66 | 4.80 | 3.77 | 3.90 | 2.85 | 2.90 | 1.52 | |
|
| 12.40 | 6.08 | 12.80 | 6.65 | 4.40 | 2.84 | 3.60 | 2.22 | |
|
|
| 11.10 | 6.08 | 4.50 | 4.12 | 4.00 | 3.89 | 3.10 | 4.18 |
|
| 10.40 | 4.81 | 4.00 | 3.97 | 2.80 | 1.75 | 2.40 | 1.84 | |
|
| 10.50 | 5.60 | 10.40 | 6.47 | 2.20 | 1.75 | 2.40 | 1.84 | |
|
|
| 18.70 | 8.77 | 25.50 | 6.65 | 25.20 | 6.12 | 25.80 | 6.00 |
|
| 20.80 | 6.75 | 26.30 | 4.62 | 26.90 | 4.18 | 26.10 | 3.67 | |
|
| 23.90 | 6.14 | 25.30 | 6.45 | 26.00 | 4.27 | 26.30 | 3.56 | |
|
|
| 17.70 | 7.09 | 10.80 | 4.59 | 10.20 | 4.66 | 8.70 | 4.40 |
|
| 21.30 | 6.40 | 10.90 | 3.11 | 10.70 | 3.62 | 9.80 | 2.90 | |
|
| 15.10 | 6.05 | 14.20 | 5.87 | 7.20 | 2.35 | 6.40 | 1.90 | |
|
|
| 61.50 | 13.29 | 64.80 | 9.24 | 64.80 | 9.57 | 65.20 | 9.10 |
|
| 60.00 | 11.92 | 64.20 | 7.86 | 64.40 | 8.21 | 65.00 | 8.01 | |
|
| 63.70 | 7.85 | 65.60 | 7.34 | 69.80 | 6.76 | 70.50 | 6.80 | |
Results of outcome measures of T1 and T2
|
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||||
|
|
| 33.90 | (29.85 to 37.95) | 9 | 18.93*** | 3.65 | 2,26 | 103.70*** | 4.01 | 1/3*** |
|
| 35.20 | (26.47 to 43.93) | 9 | 9.12*** | 4.62 | 4.31 | 2/3*** | |||
|
| 2.10 | (0.54 to 3.66) | 9 | 3.04* | 0.19 | |||||
|
|
| 7.20 | (2.00 to 12.35) | 9 | 3.17* | 1.04 | 2,26 | 40.05*** | 2.26 | 1/3*** |
|
| 14.50 | (9.21 to 19.79) | 9 | 6.20*** | 2.58 | 2.71 | 2/3*** | |||
|
| 0.10 | (−1.23 to 1.42) | 9 | 0.17 | 0.02 | |||||
|
|
| 5.90 | (3.55 to 8.25) | 9 | 5.69*** | 1.44 | 2,26 | 10.16*** | 1.42 | 1/3*** |
|
| 5.80 | (2.86 to 8.74) | 9 | 4.47** | 1.50 | 1.42 | 2/3*** | |||
|
| −0.40 | (−1.09 to 0.29) | 9 | −1.31 | 0.06 | |||||
|
|
| 6.60 | (3.98 to 9.22) | 9 | 5.71*** | 1.22 | 2,26 | 14.57*** | 1.04 | 1/3** |
|
| 6.40 | (2.36 to 10.44) | 9 | 3.59** | 1.39 | 1.14 | 2/3** | |||
|
| −1.40 | (−2.48 to −0.32) | 9 | −2.94* | 0.02 | |||||
|
|
| −6.80 | (10.90 to −2.70) | 9 | −3.75** | 0.84 | 2,26 | 1.84 | 0.03 | |
|
| −5.50 | (−9.86 to −1.14) | 9 | −2.85* | 0.91 | 0.17 | ||||
|
| 0.09 | (−1.39 to 1.58) | 9 | 0.17 | 0.21 | |||||
|
|
| 6.90 | (3.69 to10.11) | 9 | 4.87** | 1.11 | 2,26 | 9.18*** | 0.62 | 1/3* |
|
| 10.40 | (5.87 to 14.93) | 9 | 5.20*** | 1.98 | 0.67 | 2/3** | |||
|
| 0.90 | (0.27 to1.53) | 9 | 3.25* | 0.14 | |||||
|
|
| −3.30 | (−7.75 to 1.15) | 9 | −1.68 | 0.28 | 2,26 | 0.14 | 0.09 | |
|
| −4.20 | (−12.21 to 3.81) | 9 | −1.19 | 0.40 | 0.18 | ||||
|
| −1.90 | (−4.04 to 0.24) | 9 | −2.00 | 0.24 | |||||
△Means difference, 95% CI, paired t-test, within group effect sizes, ANCOVA analyses, and between group effect sizes are presented.
1 = NET group; 2 = NET-R group; 3 = WL group.
*p < 0.05;**p < 0.01;*** P < 0.001.
Figure 2Mean scores for IES-R of three groups.
Figure 3Mean scores for positive changes of three groups.
-Significant within group changes between T1-T2
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| Active coping | NET-R | 3.40 | 1.07 | 5.40 | 1.35 | 9 | 3.87** | 1.57 |
| Reframing | NET | 4.40 | 1.90 | 5.50 | 2.01 | 9 | 2.91* | 0.54 |
| NET-R | 4.70 | 1.64 | 6.70 | 1.42 | 9 | 2.68* | 1.25 | |
| Planning | NET | 4.40 | 1.65 | 6.00 | 2.00 | 9 | 2.28* | 0.84 |
| Religion | WL | 4.30 | 2.06 | 4.80 | 2.30 | 9 | 3.00* | 0.22 |
| Self-distraction | NET-R | 6.90 | 1.20 | 7.90 | 0.32 | 9 | 3.87** | 1.09 |
*p < 0.05;**p < 0.01; ***P < 0.001.